Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting
Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting
WINNIPEG, Manitoba--(BUSINESS WIRE)--The Bioscience Association Manitoba (BAM) is pleased to announce the appointment of new members to its Board of Directors and Executive Board, following the organization’s Annual General Meeting held on October 15, 2026.
The new BAM Board brings together leaders from across Manitoba’s bioscience community, representing a range of expertise, organizations, and sectors.
Share
The new BAM Board brings together leaders from across Manitoba’s bioscience community, representing a range of expertise, organizations, and sectors. Together, they will help guide BAM’s work to strengthen Manitoba’s bioscience ecosystem, support industry growth, and create opportunities for collaboration and innovation across the province.
BAM is pleased to welcome the following new members to its Board of Directors:
- Brad Elias, Winnipeg Airports Authority
- Heather Berthelette, Spirit Healthcare Group
- Henry Floreal, Taumedis
- Ian Robertson, GlaxoSmithKline (GSK)
- James Willis, Baxter Corporation
- Dr. Sarah Dentry, CancerCare Manitoba
BAM also welcome its new Executive Board members:
- Dvorah Richler, Emergent BioSolutions, Chair
- Martin Barbeau, Bausch Health, Canada, Vice-Chair
- Will Kaye, MNP LLP, Treasurer
- Kyle Brown, Moderna Canada, Secretary
"We are excited to welcome our new Directors and Executive Board members as we continue to build a strong connected bioscience ecosystem in Manitoba,” said Andrea Ladouceur, President & CEO of BAM. “Our directors bring a wealth of knowledge, experience, and perspectives from across the sector, and their leadership is incredibly valuable as we work to support the growth of Manitoba’s bioscience industry.”
BAM would also like to thank the outgoing board members for their time, leadership, and contributions to the organization. Their commitment has helped advance BAM’s mandate and strengthen Manitoba’s bioscience community.
As Past Board Chair, Reuben Saba, Vice President of Business Development at Medicure Inc., reflected on their time serving on the Board:
"Serving on the Board of Bioscience Association Manitoba has been an incredibly rewarding experience. I’m proud of what we have accomplished together and of the role BAM continues to play in bringing Manitoba’s bioscience community together,” said Saba. “I’m grateful for the opportunity to have worked alongside such dedicated industry leaders. I have every confidence that the incoming Board will continue to move BAM forward and create new opportunities for the sector.”
“We are incredibly grateful to our outgoing directors for the knowledge, perspective, and leadership they have shared with BAM,” said Ladouceur. “Their contributions have made a lasting impact, and we look forward to building on that foundation with our new Board members.”
The new Board and Executive Board members will support BAM as it continues to connect Manitoba’s bioscience community, advocate for the sector, develop talent, and create opportunities for companies and organizations to grow.
Learn more about Bioscience Association Manitoba by visiting www.biomb.ca.
About Bioscience Association Manitoba
Bioscience Association Manitoba (BAM) is a not-for-profit industry association that enables commercial success for Manitoba’s bioscience companies by acting as a catalyst for innovation, expanding the sector’s skills and workforce development, and leading with one unified voice to create local and global engagement.
Contacts
Bioscience Association Manitoba
Chloe Gerrard – Communications, Marketing, & IT Manager
chloe@biomb.ca
